ICGT ICG Enterprise Trust

ICG Enterprise Trust executes secondary sale

ICG Enterprise Trust executes secondary sale

2 April 2025

ICG Enterprise Trust executes secondary sale

ICG Enterprise Trust (“ICGT”) is pleased to announce the sale of eight mature primary fund investments, generating net cash proceeds of £62 million.

The sale was executed at a discount of 5.5% to the 30 September 2024 valuation, having received significant buyer interest. It realises a return of 1.6x invested cost (15% IRR) to ICGT, and releases undrawn commitments of £10m.

The proceeds have been received and will be deployed into opportunities in line with ICGT’s investment objectives and capital allocation policy.

Oliver Gardey and Colm Walsh, Portfolio Managers for ICG Enterprise Trust, commented:

“This is the fourth time in the last five years that ICGT has executed a secondary sale of mature fund investments, as part of our active approach to managing our Portfolio and our focus on maximising shareholder returns.

These eight primary fund investments, with vintage years ranging from 2014 to 2020, delivered good returns in aggregate for ICGT but we believe have limited future potential relative to other opportunities.

This sale allows ICGT to take advantage of a strong pricing environment and enables us to redeploy this capital into opportunities that we believe will generate additional long-term value for our shareholders.”

Enquiries

Analyst / Investor enquiries: 
Martin Li, Shareholder Relations, ICG+44 (0) 20 3545 2020
Nathan Brown, Deutsche Numis+44 (0) 20 7260 1426
David Harris, Cadarn Capital+44 (0) 20 7019 9042
Media: 
Clare Glynn, Corporate Communications, ICG+44 (0) 20 3545 1395
Website: 
-enterprise.co.uk 

About ICG Enterprise Trust

ICG Enterprise Trust is a leading listed private equity investor focused on creating long-term compounding growth by delivering consistently strong returns through selectively investing in profitable, cash-generative private companies, primarily in Europe and the US.

We invest in companies directly as well as through funds managed by ICG and other leading managers who focus on creating long-term value and building sustainable growth through active management and strategic change.

We have a long track record of delivering strong returns through a flexible mandate and highly selective approach that strikes the right balance between concentration and diversification, risk and reward.

Disclaimer        

This report may contain forward looking statements. These written materials are not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended, or an exemption therefrom. The issuer has not and does not intend to register any securities under the US Securities Act of 1933, as amended, and does not intend to offer any securities to the public in the United States. No money, securities or other consideration from any person inside the United States is being solicited and, if sent in response to the information contained in these written materials, will not be accepted.

Although this investment does not amount to price sensitive material information, ICG Enterprise Trust is making this information public on an illustrative basis to aid with market understanding of our portfolio. Similar announcements may be made in respect of future non-material investments.



EN
02/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ICG Enterprise Trust

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 3 April 2025 Transaction in Own Shares The Company announces that on 2 April 2025 it bought back 40,000 of its own shares, to be held as treasury shares, at an average price of 1252 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 9,203,808.Total shares in issue excluding treasury shares following settlement of this purchase: 63,709,192. The Company has bought back these shares under the authority granted by shareholders at its Annual Ge...

 PRESS RELEASE

ICG Enterprise Trust executes secondary sale

ICG Enterprise Trust executes secondary sale 2 April 2025 ICG Enterprise Trust executes secondary sale ICG Enterprise Trust (“ICGT”) is pleased to announce the sale of eight mature primary fund investments, generating net cash proceeds of £62 million. The sale was executed at a discount of 5.5% to the 30 September 2024 valuation, having received significant buyer interest. It realises a return of 1.6x invested cost (15% IRR) to ICGT, and releases undrawn commitments of £10m. The proceeds have been received and will be deployed into opportunities in line with ICGT’s investment objectiv...

Mark Thomas ... (+2)
  • Mark Thomas
  • Martin Hall

Hardman & Co Monthly: April 2025

Feature article: 2024 pharma statistics An efficient reporting system has seen all the listed multinational pharmaceutical companies announce results for 2024, which has given us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of global pharmaceutical market growth plus the global and US company rankings for 2024. The year was characterised by 9.2% underlying (ex-COVID-19) growth. Much of the growth was driven by recently launched ant...

 PRESS RELEASE

Voting Rights and Capital

Voting Rights and Capital ICG Enterprise Trust plc (the “Company”) 1 April 2025        Total Voting Rights In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company announces as follows. At the close of business on the 31 March 2025, the Company had 72,913,000 Ordinary shares in issue, of which 9,048,808 were held in Treasury. Therefore, the total number of voting rights in the Company is 63,864,192.The above figure 63,864,192 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify th...

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 1 April 2025 Transaction in Own Shares The Company announces that on 31 March 2025 it bought back 100,000 of its own shares, to be held as treasury shares, at an average price of 1259 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 9,163,808.Total shares in issue excluding treasury shares following settlement of this purchase: 63,749,192. The Company has bought back these shares under the authority granted by shareholders at its Annual ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch